PROSIGHT MANAGEMENT, LP Global Blood Therapeutics, Inc. Transaction History

PROSIGHT MANAGEMENT, LP portfolio value:

$0
portfolio value

PROSIGHT MANAGEMENT, LP quarter portfolio value change:

+113.15%
quarter

Global Blood Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -101.84K shares -3.25M $68.1 0
Q2 2022 share Increase 0.00% 101.84K shares 3.25M $31.95 101.84K